Skip to main content
Erschienen in: Critical Care 1/2003

01.02.2002 | Review

Bench-to-bedside review: Functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis

verfasst von: Steven M Opal, Charles T Esmon

Erschienen in: Critical Care | Ausgabe 1/2003

Einloggen, um Zugang zu erhalten

Abstract

The innate immune response system is designed to alert the host rapidly to the presence of an invasive microbial pathogen that has breached the integument of multicellular eukaryotic organisms. Microbial invasion poses an immediate threat to survival, and a vigorous defense response ensues in an effort to clear the pathogen from the internal milieu of the host. The innate immune system is able to eradicate many microbial pathogens directly, or innate immunity may indirectly facilitate the removal of pathogens by activation of specific elements of the adaptive immune response (cell-mediated and humoral immunity by T cells and B cells). The coagulation system has traditionally been viewed as an entirely separate system that has arisen to prevent or limit loss of blood volume and blood components following mechanical injury to the circulatory system. It is becoming increasingly clear that coagulation and innate immunity have coevolved from a common ancestral substrate early in eukaryotic development, and that these systems continue to function as a highly integrated unit for survival defense following tissue injury. The mechanisms by which these highly complex and coregulated defense strategies are linked together are the focus of the present review.
Literatur
1.
Zurück zum Zitat Levi M, ten Cate H: Disseminated intravascular coagulation. N Engl J Med 1999, 341: 586-592. 10.1056/NEJM199908193410807PubMed Levi M, ten Cate H: Disseminated intravascular coagulation. N Engl J Med 1999, 341: 586-592. 10.1056/NEJM199908193410807PubMed
2.
Zurück zum Zitat Vervloet MG, Thijs LG, Hack CE: Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock. Semin Thromb Hemost 1998, 24: 33-44.PubMed Vervloet MG, Thijs LG, Hack CE: Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock. Semin Thromb Hemost 1998, 24: 33-44.PubMed
3.
Zurück zum Zitat Lorente JA, García-Frade LJ, Landín L, dePablo R, Torrado C, Renes E, Garcí-Avello A: Time course of hemostatic abnormalities in sepsis and its relation to outcome. Chest 1993, 103: 1536-1542.PubMed Lorente JA, García-Frade LJ, Landín L, dePablo R, Torrado C, Renes E, Garcí-Avello A: Time course of hemostatic abnormalities in sepsis and its relation to outcome. Chest 1993, 103: 1536-1542.PubMed
4.
Zurück zum Zitat O'Neill LA, Greene C: Signal transduction pathway is activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J Leukoc Biol 1998, 63: 650-657.PubMed O'Neill LA, Greene C: Signal transduction pathway is activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J Leukoc Biol 1998, 63: 650-657.PubMed
5.
Zurück zum Zitat Opal SM, Huber CE: The Toll-like receptors and their role in septic shock. Crit Care 2002, 6: 125-136. 10.1186/cc1471PubMedCentralPubMed Opal SM, Huber CE: The Toll-like receptors and their role in septic shock. Crit Care 2002, 6: 125-136. 10.1186/cc1471PubMedCentralPubMed
6.
Zurück zum Zitat Levin J, Bang FB: The role of endotoxin in the extracellular coagulation of Limulus blood. Bull Johns Hopkins Hosp 1964, 115: 265-274.PubMed Levin J, Bang FB: The role of endotoxin in the extracellular coagulation of Limulus blood. Bull Johns Hopkins Hosp 1964, 115: 265-274.PubMed
7.
Zurück zum Zitat Kawabata S-I: Molecular basis of non-self recognition by horeshoe crab lectins. J Endotoxin Res 2002, 8: 175-176. 10.1179/096805102125001037 Kawabata S-I: Molecular basis of non-self recognition by horeshoe crab lectins. J Endotoxin Res 2002, 8: 175-176. 10.1179/096805102125001037
8.
Zurück zum Zitat Rietschel ET, Westphal O: Endotoxin: historical perspectives. In Endotoxin in Health and Disease (Edited by: Brade H, Opal SM, Vogel SN, Morrison D). New York: Marcel Dekker Inc 1999, 1-30. Rietschel ET, Westphal O: Endotoxin: historical perspectives. In Endotoxin in Health and Disease (Edited by: Brade H, Opal SM, Vogel SN, Morrison D). New York: Marcel Dekker Inc 1999, 1-30.
9.
Zurück zum Zitat Turner MW: Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today 1996, 17: 532-540. 10.1016/0167-5699(96)10062-1PubMed Turner MW: Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today 1996, 17: 532-540. 10.1016/0167-5699(96)10062-1PubMed
10.
Zurück zum Zitat Wolbink G-J, Bossink AWJ, Groeneveld ABJ, DeGroot MCM, Thijs LG, Hack CE: Complement activation in patients with sepsis is in part mediated by C-reactive protein. J Infect Dis 1998, 177: 81-87.PubMed Wolbink G-J, Bossink AWJ, Groeneveld ABJ, DeGroot MCM, Thijs LG, Hack CE: Complement activation in patients with sepsis is in part mediated by C-reactive protein. J Infect Dis 1998, 177: 81-87.PubMed
11.
Zurück zum Zitat Dries DJ: Activation of the clotting system and complement after trauma. New Horizons 1996, 4: 278-288. Dries DJ: Activation of the clotting system and complement after trauma. New Horizons 1996, 4: 278-288.
12.
Zurück zum Zitat Pugin J, Heumann ID, Tomasz A, Kravchenko VV, Akamatsu Y, Nishijima M, Glauser MP, Tobias PS, Ulevitch RJ: CD14 is a pattern recognition receptor. Immunity 1994, 1: 509-516.PubMed Pugin J, Heumann ID, Tomasz A, Kravchenko VV, Akamatsu Y, Nishijima M, Glauser MP, Tobias PS, Ulevitch RJ: CD14 is a pattern recognition receptor. Immunity 1994, 1: 509-516.PubMed
13.
Zurück zum Zitat Novitsky TJ: Limulus amebocyte lysate (LAL) detection of endotoxin in human blood. J Endotoxin Res 1994, 1: 253-263. Novitsky TJ: Limulus amebocyte lysate (LAL) detection of endotoxin in human blood. J Endotoxin Res 1994, 1: 253-263.
14.
Zurück zum Zitat Hoess A, Watson S, Siber GR, Liddington R: Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab, Limulus anti-LPS factor, at 1.5 Å resolution. EMBO J 1993, 12: 3351-3356.PubMedCentralPubMed Hoess A, Watson S, Siber GR, Liddington R: Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab, Limulus anti-LPS factor, at 1.5 Å resolution. EMBO J 1993, 12: 3351-3356.PubMedCentralPubMed
15.
Zurück zum Zitat Opal SM: The phylogenetic relationships between the coagulation system and the inflammatory networks. Crit Care Med 2000,28(suppl):S77-S82.PubMed Opal SM: The phylogenetic relationships between the coagulation system and the inflammatory networks. Crit Care Med 2000,28(suppl):S77-S82.PubMed
16.
Zurück zum Zitat van Gorp EC, Suharti C, ten Cate H, Dolmans WM, van der Meer JW, ten Cate JW, Brandjes DP: Review: infectious diseases and coagulation disorders. J Infect Dis 1999, 180: 176-186. 10.1086/314829PubMed van Gorp EC, Suharti C, ten Cate H, Dolmans WM, van der Meer JW, ten Cate JW, Brandjes DP: Review: infectious diseases and coagulation disorders. J Infect Dis 1999, 180: 176-186. 10.1086/314829PubMed
17.
Zurück zum Zitat Mavrommatis AC, Theodoridis T, Orfanidou A, Roussos C, Christopoulou-Kokkinou V, Zakynthinos S: Coagulation system and platelets are fully activated in uncomplicated sepsis. Crit Care Med 2000, 28: 451-457. 10.1097/00003246-200002000-00027PubMed Mavrommatis AC, Theodoridis T, Orfanidou A, Roussos C, Christopoulou-Kokkinou V, Zakynthinos S: Coagulation system and platelets are fully activated in uncomplicated sepsis. Crit Care Med 2000, 28: 451-457. 10.1097/00003246-200002000-00027PubMed
18.
Zurück zum Zitat Esmon CT: Are natural anticoagulants candidates for modulating the inflammatory response to endotoxin? Blood 2000, 96: 1113-1116. Esmon CT: Are natural anticoagulants candidates for modulating the inflammatory response to endotoxin? Blood 2000, 96: 1113-1116.
19.
Zurück zum Zitat Carvalho AC, Freeman NJ: How coagulation defects alter the outcome of sepsis:survival may depend on reversing the procoagulant conditions. J Crit Illness 1994, 9: 51-75. Carvalho AC, Freeman NJ: How coagulation defects alter the outcome of sepsis:survival may depend on reversing the procoagulant conditions. J Crit Illness 1994, 9: 51-75.
20.
Zurück zum Zitat Hinshaw LB: Sepsis/septic shock: participation of the microcirculation: an abbreviated review. Crit Care Med 1996, 24: 1072-1078. 10.1097/00003246-199606000-00031PubMed Hinshaw LB: Sepsis/septic shock: participation of the microcirculation: an abbreviated review. Crit Care Med 1996, 24: 1072-1078. 10.1097/00003246-199606000-00031PubMed
21.
Zurück zum Zitat Taylor FB Jr, Stearns-Kurosawa DJ, Kurosawa S, Ferrell G, Chang AC, Laszik Z, Kosanke S, Peer G, Esmon CT: The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis. Blood 2000, 95: 1680-1686.PubMed Taylor FB Jr, Stearns-Kurosawa DJ, Kurosawa S, Ferrell G, Chang AC, Laszik Z, Kosanke S, Peer G, Esmon CT: The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis. Blood 2000, 95: 1680-1686.PubMed
22.
Zurück zum Zitat Esmon CT: The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989, 264: 4743-4746.PubMed Esmon CT: The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989, 264: 4743-4746.PubMed
23.
Zurück zum Zitat Murakami K, Okajima K, Uchida M, Johno M, Nakagaki T, Okobe H, Takatsuki K: Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production. Am J Physiol 1997, 272: L197-L202.PubMed Murakami K, Okajima K, Uchida M, Johno M, Nakagaki T, Okobe H, Takatsuki K: Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production. Am J Physiol 1997, 272: L197-L202.PubMed
24.
Zurück zum Zitat Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr, Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group: Efficacy and safety of recombinant human activated Protein C for severe sepsis. N Engl J Med 2001, 344: 699-709. 10.1056/NEJM200103083441001PubMed Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr, Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group: Efficacy and safety of recombinant human activated Protein C for severe sepsis. N Engl J Med 2001, 344: 699-709. 10.1056/NEJM200103083441001PubMed
25.
Zurück zum Zitat Kirschner M, Gerhart J: Evolvability. Proc Natl Acad Sci USA 1998, 95: 8240-8427. 10.1073/pnas.95.15.8420 Kirschner M, Gerhart J: Evolvability. Proc Natl Acad Sci USA 1998, 95: 8240-8427. 10.1073/pnas.95.15.8420
26.
Zurück zum Zitat Pixley RA, De La Cadena R, Page JD, Kaufman N, Wyshock EG, Chang A, Taylor FB, Colman RW: The contact system contributes to hypotension but not to disseminated intravascular coagulation in lethal bacteremia. J Clin Invest 1993, 91: 61-70.PubMedCentralPubMed Pixley RA, De La Cadena R, Page JD, Kaufman N, Wyshock EG, Chang A, Taylor FB, Colman RW: The contact system contributes to hypotension but not to disseminated intravascular coagulation in lethal bacteremia. J Clin Invest 1993, 91: 61-70.PubMedCentralPubMed
27.
Zurück zum Zitat Drake TA, Morrissey JH, Edgington TS: Selective cellular expression of tissue factor in human tissues: Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989, 134: 1087-1097.PubMedCentralPubMed Drake TA, Morrissey JH, Edgington TS: Selective cellular expression of tissue factor in human tissues: Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989, 134: 1087-1097.PubMedCentralPubMed
28.
Zurück zum Zitat Randolph MM, White GL, Kosanke SD, Bild G, Carr C, Galluppi G, Hinshaw LB, Taylor FB Jr: Attenuation of tissue thrombosis and hemorrhage by ala-TFPI does not account for its protection against E. coli : a comparative study of treated and untreated non-surviving baboons challenged with LD100 E. coli . Thromb Haemost 1998, 79: 1048-1053.PubMed Randolph MM, White GL, Kosanke SD, Bild G, Carr C, Galluppi G, Hinshaw LB, Taylor FB Jr: Attenuation of tissue thrombosis and hemorrhage by ala-TFPI does not account for its protection against E. coli : a comparative study of treated and untreated non-surviving baboons challenged with LD100 E. coli . Thromb Haemost 1998, 79: 1048-1053.PubMed
29.
Zurück zum Zitat Drake TA, Cheng J, Chang A, Taylor FB Jr: Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal E. coli sepsis. Am J Pathol 1993, 142: 1458-1470.PubMedCentralPubMed Drake TA, Cheng J, Chang A, Taylor FB Jr: Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal E. coli sepsis. Am J Pathol 1993, 142: 1458-1470.PubMedCentralPubMed
30.
Zurück zum Zitat Wheeler AP, Bernard G: Treating patients with severe sepsis. N Engl J Med 1999, 340: 207-214. 10.1056/NEJM199901213400307PubMed Wheeler AP, Bernard G: Treating patients with severe sepsis. N Engl J Med 1999, 340: 207-214. 10.1056/NEJM199901213400307PubMed
31.
Zurück zum Zitat Astiz ME, Rackow EC: Septic shock. Lancet 1998, 351: 1501-1505. 10.1016/S0140-6736(98)01134-9PubMed Astiz ME, Rackow EC: Septic shock. Lancet 1998, 351: 1501-1505. 10.1016/S0140-6736(98)01134-9PubMed
32.
Zurück zum Zitat Beutler B, Poltorak A: Sepsis and evolution of the innate immune response. Crit Care Med 2001,29(suppl):S2-S6.PubMed Beutler B, Poltorak A: Sepsis and evolution of the innate immune response. Crit Care Med 2001,29(suppl):S2-S6.PubMed
33.
Zurück zum Zitat Beutler B: Sepsis begins at the interface of pathogen and host. Biochem Soc Trans 2001, 29: 853-859. 10.1042/0300-5127:0290853PubMed Beutler B: Sepsis begins at the interface of pathogen and host. Biochem Soc Trans 2001, 29: 853-859. 10.1042/0300-5127:0290853PubMed
34.
Zurück zum Zitat Lauener RP, Birchler T, Adamski J, Braun-Fahrlander C, Bufe A, Herz U, von Mutius E, Nowak D, Riedler J, Waser M, Sennhauser FH, ALEX study group: Expression of CD14 and Toll-like receptor 2 in farmers' and non-farmers' children. Lancet 2002, 360: 465-466. 10.1016/S0140-6736(02)09641-1PubMed Lauener RP, Birchler T, Adamski J, Braun-Fahrlander C, Bufe A, Herz U, von Mutius E, Nowak D, Riedler J, Waser M, Sennhauser FH, ALEX study group: Expression of CD14 and Toll-like receptor 2 in farmers' and non-farmers' children. Lancet 2002, 360: 465-466. 10.1016/S0140-6736(02)09641-1PubMed
35.
Zurück zum Zitat Bach J-F: Mechanisms of disease: the effect of infections on the susceptibility to autoimmune and allergic diseases. N Engl J Med 2002, 347: 911-920. 10.1056/NEJMra020100PubMed Bach J-F: Mechanisms of disease: the effect of infections on the susceptibility to autoimmune and allergic diseases. N Engl J Med 2002, 347: 911-920. 10.1056/NEJMra020100PubMed
36.
Zurück zum Zitat Medzhitov R, Janeway C: Innate immunity. N Engl J Med 2000, 343: 338-344. 10.1056/NEJM200008033430506PubMed Medzhitov R, Janeway C: Innate immunity. N Engl J Med 2000, 343: 338-344. 10.1056/NEJM200008033430506PubMed
37.
Zurück zum Zitat Fenton MJ, Golenbock DT: LPS-binding proteins and receptors. J Leukoc Biol 1998, 64: 25-32.PubMed Fenton MJ, Golenbock DT: LPS-binding proteins and receptors. J Leukoc Biol 1998, 64: 25-32.PubMed
38.
Zurück zum Zitat Antal-Szalmas P: Evaluation of CD14 in host defense. Eur J Clin Invest 2000, 30: 167-179. 10.1046/j.1365-2362.2000.00610.xPubMed Antal-Szalmas P: Evaluation of CD14 in host defense. Eur J Clin Invest 2000, 30: 167-179. 10.1046/j.1365-2362.2000.00610.xPubMed
39.
Zurück zum Zitat Landmann R, Müller B, Zimmerli W: CD14, new aspects of ligand and signal diversity. Microb Infect 2000, 2: 295-304. 10.1016/S1286-4579(00)00298-7 Landmann R, Müller B, Zimmerli W: CD14, new aspects of ligand and signal diversity. Microb Infect 2000, 2: 295-304. 10.1016/S1286-4579(00)00298-7
40.
Zurück zum Zitat Poltorak A, He X, Smirnova I, Liu MY, Huffel CV, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B: Defective signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282: 2085-2088. 10.1126/science.282.5396.2085PubMed Poltorak A, He X, Smirnova I, Liu MY, Huffel CV, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B: Defective signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282: 2085-2088. 10.1126/science.282.5396.2085PubMed
41.
Zurück zum Zitat Pfeiffer A, Bottcher A, Orso E, Kapinsky M, Nagy P, Bodnar A, Spreitzer I, Liebisch G, Drobnik W, Gempel K, Horn M, Holmer S, Hartung T, Multhoff G, Schutz G, Schindler H, Ulmer AJ, Heine H, Stelter F, Schutt C, Rothe G, Szollosi J, Damjanovich S, Schmitz G: Lipopolysaccharide and ceramide docking to CD14 provokes ligand specific receptor clustering in rafts. Eur J Immunol 2001, 31: 3153-3164. 10.1002/1521-4141(200111)31:11<3153::AID-IMMU3153>3.0.CO;2-0PubMed Pfeiffer A, Bottcher A, Orso E, Kapinsky M, Nagy P, Bodnar A, Spreitzer I, Liebisch G, Drobnik W, Gempel K, Horn M, Holmer S, Hartung T, Multhoff G, Schutz G, Schindler H, Ulmer AJ, Heine H, Stelter F, Schutt C, Rothe G, Szollosi J, Damjanovich S, Schmitz G: Lipopolysaccharide and ceramide docking to CD14 provokes ligand specific receptor clustering in rafts. Eur J Immunol 2001, 31: 3153-3164. 10.1002/1521-4141(200111)31:11<3153::AID-IMMU3153>3.0.CO;2-0PubMed
42.
Zurück zum Zitat Means TK, Golenbock DT, Fenton MJ: The biology of toll-like receptors. Cytokine Growth Factor Rev 2000, 11: 219-232. 10.1016/S1359-6101(00)00006-XPubMed Means TK, Golenbock DT, Fenton MJ: The biology of toll-like receptors. Cytokine Growth Factor Rev 2000, 11: 219-232. 10.1016/S1359-6101(00)00006-XPubMed
43.
Zurück zum Zitat ten Cate H: Pathophysiology of disseminated intravascular coagulation in sepsis. Crit Care Med 2000, 28: S9-S11. 10.1097/00003246-200009001-00003PubMed ten Cate H: Pathophysiology of disseminated intravascular coagulation in sepsis. Crit Care Med 2000, 28: S9-S11. 10.1097/00003246-200009001-00003PubMed
44.
Zurück zum Zitat Abraham E: Coagulation abnormalities in acute lung injury and sepsis. Am J Respir Cell Mol Biol 2000, 22: 401-404.PubMed Abraham E: Coagulation abnormalities in acute lung injury and sepsis. Am J Respir Cell Mol Biol 2000, 22: 401-404.PubMed
45.
Zurück zum Zitat Abraham E: Tissue factor inhibition and clinical trial results of tissue factor pathway inhibitor in sepsis. Crit Care Med 2000, 28: S31-S33. 10.1097/00003246-200009001-00007PubMed Abraham E: Tissue factor inhibition and clinical trial results of tissue factor pathway inhibitor in sepsis. Crit Care Med 2000, 28: S31-S33. 10.1097/00003246-200009001-00007PubMed
46.
Zurück zum Zitat Levi M: Keep in contact: the role of the contact system in infection and sepsis. Crit Care Med 2000, 28: 3765-3766.PubMed Levi M: Keep in contact: the role of the contact system in infection and sepsis. Crit Care Med 2000, 28: 3765-3766.PubMed
47.
Zurück zum Zitat Aird WC: Vascular bed-specific hemostasis: role of endothelium in sepsis pathogenesis. Crit Care Med 2001, 29: S28-S35. 10.1097/00003246-200107001-00013PubMed Aird WC: Vascular bed-specific hemostasis: role of endothelium in sepsis pathogenesis. Crit Care Med 2001, 29: S28-S35. 10.1097/00003246-200107001-00013PubMed
48.
Zurück zum Zitat Sriskandan S, Kemball-Cook G, Moyes D, Canvin J, Tuddenham E, Cohen J: Contact activation in shock caused by invasive group A Streptococcus pyogenes . Crit Care Med 2000, 28: 3684-3691.PubMed Sriskandan S, Kemball-Cook G, Moyes D, Canvin J, Tuddenham E, Cohen J: Contact activation in shock caused by invasive group A Streptococcus pyogenes . Crit Care Med 2000, 28: 3684-3691.PubMed
49.
Zurück zum Zitat Johnson K, Choi Y, DeGroot E, Samuels I, Creasey A, Aarden L: Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation. J Immunol 1998, 160: 5130-5135.PubMed Johnson K, Choi Y, DeGroot E, Samuels I, Creasey A, Aarden L: Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation. J Immunol 1998, 160: 5130-5135.PubMed
50.
Zurück zum Zitat Volk T, Kox WJ: Endothelium function in sepsis. Inflamm Res 2000, 49: 185-198. 10.1007/s000110050579PubMed Volk T, Kox WJ: Endothelium function in sepsis. Inflamm Res 2000, 49: 185-198. 10.1007/s000110050579PubMed
51.
Zurück zum Zitat Mirlashari MR, Høiby EA, Holst J, Lyberg T: Outer membrane vesicles from Neisseria meningitidis : effects on tissue factor and plasminogen activator inhibitor-2 production in human monocytes. Thrombosis Res 2001, 102: 375-380. 10.1016/S0049-3848(01)00256-0 Mirlashari MR, Høiby EA, Holst J, Lyberg T: Outer membrane vesicles from Neisseria meningitidis : effects on tissue factor and plasminogen activator inhibitor-2 production in human monocytes. Thrombosis Res 2001, 102: 375-380. 10.1016/S0049-3848(01)00256-0
52.
Zurück zum Zitat ten Cate H, Bauer KA, Levi M, Edgington TS, Sublett RD, Barzegar S, Kass BL, Rosenberg RD: The activation of factor X and prothrombin by recombinant factor VII in vivo is mediated by tissue factor. J Clin Invest 1993, 92: 1207-1212.PubMedCentralPubMed ten Cate H, Bauer KA, Levi M, Edgington TS, Sublett RD, Barzegar S, Kass BL, Rosenberg RD: The activation of factor X and prothrombin by recombinant factor VII in vivo is mediated by tissue factor. J Clin Invest 1993, 92: 1207-1212.PubMedCentralPubMed
53.
Zurück zum Zitat Tapper Hans, Herwald H: Modulation of hemostatic mechanisms in bacterial infectious diseases. Blood 2000, 96: 2329-2337.PubMed Tapper Hans, Herwald H: Modulation of hemostatic mechanisms in bacterial infectious diseases. Blood 2000, 96: 2329-2337.PubMed
54.
Zurück zum Zitat Voss R, Matthias FR, Borkowski G, Reitz D: Activation and inhibition of fibrinolysis in septic patients in an internal medicine intensive care unit. Br J Haematol 1990, 75: 99-105.PubMed Voss R, Matthias FR, Borkowski G, Reitz D: Activation and inhibition of fibrinolysis in septic patients in an internal medicine intensive care unit. Br J Haematol 1990, 75: 99-105.PubMed
55.
Zurück zum Zitat Hajjar K: Fibrinolysis. In: Hematology of Infancy and Childhood (Edited by: Nathan D, George JN). Philadelphia: Lippincott, Williams & Wilkins 1997, 1553-1573. Hajjar K: Fibrinolysis. In: Hematology of Infancy and Childhood (Edited by: Nathan D, George JN). Philadelphia: Lippincott, Williams & Wilkins 1997, 1553-1573.
56.
Zurück zum Zitat Bajzar L, Nesheim M, Tracy PB: The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent. Blood 1996, 88: 2093-2100.PubMed Bajzar L, Nesheim M, Tracy PB: The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent. Blood 1996, 88: 2093-2100.PubMed
57.
Zurück zum Zitat Nesheim M, Wang W, Boffa M, Nagashima M, Morser J, Bajzar L: Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis. Thromb Haemost 1997, 78: 386-391.PubMed Nesheim M, Wang W, Boffa M, Nagashima M, Morser J, Bajzar L: Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis. Thromb Haemost 1997, 78: 386-391.PubMed
58.
Zurück zum Zitat Bajzar L, Morser J, Nesheim M: TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J Biol Chem 1996, 271: 16603-16608. 10.1074/jbc.271.28.16603PubMed Bajzar L, Morser J, Nesheim M: TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J Biol Chem 1996, 271: 16603-16608. 10.1074/jbc.271.28.16603PubMed
59.
Zurück zum Zitat Hermans PWM, Hibberd ML, Booy R, Daramola D, Hazelzet JA, de Groot R, Levin M, and the meningococcal research group: 4G-5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Lancet 1999, 354: 556-560. 10.1016/S0140-6736(99)02220-5PubMed Hermans PWM, Hibberd ML, Booy R, Daramola D, Hazelzet JA, de Groot R, Levin M, and the meningococcal research group: 4G-5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Lancet 1999, 354: 556-560. 10.1016/S0140-6736(99)02220-5PubMed
60.
Zurück zum Zitat Henry M, Aubert H, Morange PE, Nanni I, Alessi MC, Tiret L, Juhan-Vague I: Identification of polymorphisms in the promoter and the 3' region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlled. Blood 2001, 97: 2053-2058. 10.1182/blood.V97.7.2053PubMed Henry M, Aubert H, Morange PE, Nanni I, Alessi MC, Tiret L, Juhan-Vague I: Identification of polymorphisms in the promoter and the 3' region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlled. Blood 2001, 97: 2053-2058. 10.1182/blood.V97.7.2053PubMed
61.
Zurück zum Zitat Hack CE: Tissue factor pathway of coagulation in sepsis. Crit Care Med 2000,28(suppl):S25-S30.PubMed Hack CE: Tissue factor pathway of coagulation in sepsis. Crit Care Med 2000,28(suppl):S25-S30.PubMed
62.
Zurück zum Zitat Faucette KJ, Parker CJ, McCluskey T, Bernshaw NJ, Rodgers GM: Induction of tissue factor activity in endothelial cells and monocytes by a modified form of albumin present in normal human plasma. Blood 1992, 79: 2888-2895.PubMed Faucette KJ, Parker CJ, McCluskey T, Bernshaw NJ, Rodgers GM: Induction of tissue factor activity in endothelial cells and monocytes by a modified form of albumin present in normal human plasma. Blood 1992, 79: 2888-2895.PubMed
63.
Zurück zum Zitat Lupu C, Lupu F, Dennehy U, Kakkar VV, Scully MF: Thrombin induces the redistribution and acute release of tissue factor pathway inhibitor from specific granules within human endothelial cells in culture. Arterioscler Thromb Vasc Biol 1995, 15: 2055-2062.PubMed Lupu C, Lupu F, Dennehy U, Kakkar VV, Scully MF: Thrombin induces the redistribution and acute release of tissue factor pathway inhibitor from specific granules within human endothelial cells in culture. Arterioscler Thromb Vasc Biol 1995, 15: 2055-2062.PubMed
64.
Zurück zum Zitat Bajaj MS, Bajaj SP: Tissue factor pathway inhibitor: potential therapeutic applications. Thromb Haemost 1997, 78: 471-477.PubMed Bajaj MS, Bajaj SP: Tissue factor pathway inhibitor: potential therapeutic applications. Thromb Haemost 1997, 78: 471-477.PubMed
65.
Zurück zum Zitat Enkhbaatar P, Okajima K, Murakami K, Uchiba M, Okabe H, Okabe K, Yamaguchi Y: Recombinant tissue factor pathway inhibitor reduces lipopolysaccharide-induced pulmonary vascular injury by inhibiting leukocyte activation. Am J Respir Crit Care Med 1997, 162: 1752-1759. Enkhbaatar P, Okajima K, Murakami K, Uchiba M, Okabe H, Okabe K, Yamaguchi Y: Recombinant tissue factor pathway inhibitor reduces lipopolysaccharide-induced pulmonary vascular injury by inhibiting leukocyte activation. Am J Respir Crit Care Med 1997, 162: 1752-1759.
66.
Zurück zum Zitat Huang Z-F, Higuchi D, Lasky N, Broze GJ Jr: Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. Blood 1997, 90: 944-951.PubMed Huang Z-F, Higuchi D, Lasky N, Broze GJ Jr: Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. Blood 1997, 90: 944-951.PubMed
67.
Zurück zum Zitat Sandset PM, Warn-Cramer BJ, Maki SL, Rapaport SI: Immunodepletion of extrinsic pathway inhibitor sensitizes rabbits to endotoxin-induced intravascular coagulation and the generalized Shwartzman reaction. Blood 1991, 78: 1496-1502.PubMed Sandset PM, Warn-Cramer BJ, Maki SL, Rapaport SI: Immunodepletion of extrinsic pathway inhibitor sensitizes rabbits to endotoxin-induced intravascular coagulation and the generalized Shwartzman reaction. Blood 1991, 78: 1496-1502.PubMed
68.
Zurück zum Zitat Opal SM, Palardy JE, Parejo NA, Creasey AA: The activity of tissue factor pathway inhibitor in experimental models of superantigen-induced shock and polymicrobial intra-abdominal sepsis. Crit Care Med 2001, 29: 13-17. 10.1097/00003246-200101000-00003PubMed Opal SM, Palardy JE, Parejo NA, Creasey AA: The activity of tissue factor pathway inhibitor in experimental models of superantigen-induced shock and polymicrobial intra-abdominal sepsis. Crit Care Med 2001, 29: 13-17. 10.1097/00003246-200101000-00003PubMed
69.
Zurück zum Zitat Yoshimura N, Kobayashi Y, Nakamura K, Yamagishi H, Oka T: The effect of tissue factor pathway inhibitor on hepatic ischemic reperfusion injury of the rat. Transplantation 1999, 67: 43-53. Yoshimura N, Kobayashi Y, Nakamura K, Yamagishi H, Oka T: The effect of tissue factor pathway inhibitor on hepatic ischemic reperfusion injury of the rat. Transplantation 1999, 67: 43-53.
70.
Zurück zum Zitat Creasey AA, Chang AC, Feigen L, Wun TC, Taylor FB Jr, Hinshaw LB: Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest 1993, 91: 2850-2856.PubMedCentralPubMed Creasey AA, Chang AC, Feigen L, Wun TC, Taylor FB Jr, Hinshaw LB: Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest 1993, 91: 2850-2856.PubMedCentralPubMed
71.
Zurück zum Zitat Dickneite G: Antithrombin III in animal models of sepsis and organ failure. Semin Thromb Hemostas 1998, 24: 61-69. Dickneite G: Antithrombin III in animal models of sepsis and organ failure. Semin Thromb Hemostas 1998, 24: 61-69.
72.
Zurück zum Zitat Eisele B, Lamy M: Clinical experience with antithrombin III concentrates in critically ill patients with sepsis and multiple organ failure. Semin Thromb Hemost 1998, 24: 71-80.PubMed Eisele B, Lamy M: Clinical experience with antithrombin III concentrates in critically ill patients with sepsis and multiple organ failure. Semin Thromb Hemost 1998, 24: 71-80.PubMed
73.
Zurück zum Zitat Gan Z-R, Li Y, Chen Z, Lewis SD, Shafer JA: Identification of basic amino acid residues in thrombin essential for heparincatalyzed inactivation by antithrombin III. J Biol Chem 1994, 269: 1301-1305.PubMed Gan Z-R, Li Y, Chen Z, Lewis SD, Shafer JA: Identification of basic amino acid residues in thrombin essential for heparincatalyzed inactivation by antithrombin III. J Biol Chem 1994, 269: 1301-1305.PubMed
74.
Zurück zum Zitat Jesty J, Lorenz A, Rodriguez J, Wun TC: Initiation of tissue factor pathway of coagulation in the presence of heparin: control by antithrombin III and tissue factor pathway inhibitor. Blood 1996, 15: 2301-2307. Jesty J, Lorenz A, Rodriguez J, Wun TC: Initiation of tissue factor pathway of coagulation in the presence of heparin: control by antithrombin III and tissue factor pathway inhibitor. Blood 1996, 15: 2301-2307.
75.
Zurück zum Zitat Rao LVM, Nordfang O, Hoand AD, Pendurthi UR: Mechanism of antithrombin III inhibition of factor VIIa/tissue factor activity on cell surfaces. comparison with tissue factor pathway inhibitor/factor Xa-induced inhibition of factor VIIa/tissue factor activity. Blood 1995, 85: 121-129.PubMed Rao LVM, Nordfang O, Hoand AD, Pendurthi UR: Mechanism of antithrombin III inhibition of factor VIIa/tissue factor activity on cell surfaces. comparison with tissue factor pathway inhibitor/factor Xa-induced inhibition of factor VIIa/tissue factor activity. Blood 1995, 85: 121-129.PubMed
76.
Zurück zum Zitat Jordan RE, Kilpatrick J, Nelson RM: Heparin promotes the inactivation of antithrombin by elastase. Science 1987, 237: 777-779.PubMed Jordan RE, Kilpatrick J, Nelson RM: Heparin promotes the inactivation of antithrombin by elastase. Science 1987, 237: 777-779.PubMed
77.
Zurück zum Zitat Niessen RW, Lamping RJ, Jansen PM, Prins MH, Peters M, Taylor FB Jr, de Vijlder JJ, ten Cate JW, Hack CE, Sturk A: Antithrombin acts as a negative acute phase protein as established with studies on HepG2 cells and in baboons. Thromb Haemost 1997, 78: 1088-1092.PubMed Niessen RW, Lamping RJ, Jansen PM, Prins MH, Peters M, Taylor FB Jr, de Vijlder JJ, ten Cate JW, Hack CE, Sturk A: Antithrombin acts as a negative acute phase protein as established with studies on HepG2 cells and in baboons. Thromb Haemost 1997, 78: 1088-1092.PubMed
78.
Zurück zum Zitat Fourrier F, Chopin C, Goudemand J, Hendrycx S, Caron C, Rime A, Marey A, Lestavel P: Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 1992, 101: 816-823.PubMed Fourrier F, Chopin C, Goudemand J, Hendrycx S, Caron C, Rime A, Marey A, Lestavel P: Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 1992, 101: 816-823.PubMed
79.
Zurück zum Zitat Mesters RM, Mannucci PM, Coppola R, Keller T, Ostermann H, Kienast J: Factor VII and antithrombin III activity during sepsis and septic shock in neutropenic patients. Blood 1996, 88: 881-886.PubMed Mesters RM, Mannucci PM, Coppola R, Keller T, Ostermann H, Kienast J: Factor VII and antithrombin III activity during sepsis and septic shock in neutropenic patients. Blood 1996, 88: 881-886.PubMed
80.
Zurück zum Zitat Uchida M, Okajima K, Murakami K: Effects of various doses of antithrombin III and endotoxin-induced endothelial cell injury and coagulation abnormalities in rats. Thromb Res 1998, 89: 233-241. 10.1016/S0049-3848(98)00012-7 Uchida M, Okajima K, Murakami K: Effects of various doses of antithrombin III and endotoxin-induced endothelial cell injury and coagulation abnormalities in rats. Thromb Res 1998, 89: 233-241. 10.1016/S0049-3848(98)00012-7
81.
Zurück zum Zitat Yamauchi T, Umeda F, Inoguchi I, Nawata H: Antithrombin III stimulates prostacyclin production by cultured aortic endothelial cells. Biochem Biophys Res Commun 1989, 163: 1404-1411.PubMed Yamauchi T, Umeda F, Inoguchi I, Nawata H: Antithrombin III stimulates prostacyclin production by cultured aortic endothelial cells. Biochem Biophys Res Commun 1989, 163: 1404-1411.PubMed
82.
Zurück zum Zitat Horie S, Ichii H, Kazama M: Heparin-like glycosaminoglycan is a receptor for antithrombin III-dependent but not thrombin-dependent prostacyclin production in human endothelial cells. Thromb Res 1990, 59: 899-904. Horie S, Ichii H, Kazama M: Heparin-like glycosaminoglycan is a receptor for antithrombin III-dependent but not thrombin-dependent prostacyclin production in human endothelial cells. Thromb Res 1990, 59: 899-904.
83.
Zurück zum Zitat Uchiba M, Okajima K: Antithrombin III prevents LPS-induced vascular injury: novel biological activity of antithrombin III. Semin Thromb Hemost 1997, 23: 583-590.PubMed Uchiba M, Okajima K: Antithrombin III prevents LPS-induced vascular injury: novel biological activity of antithrombin III. Semin Thromb Hemost 1997, 23: 583-590.PubMed
84.
Zurück zum Zitat Ostrovsky L, Woodmann RC, Payne D, Teoh D, Kubes P: Antithrombin III prevents and rapidly reverses leukocyte recruitment in ischemia/reperfusion. Circulation 1997, 96: 2302-2310.PubMed Ostrovsky L, Woodmann RC, Payne D, Teoh D, Kubes P: Antithrombin III prevents and rapidly reverses leukocyte recruitment in ischemia/reperfusion. Circulation 1997, 96: 2302-2310.PubMed
85.
Zurück zum Zitat Dunzendorfer S, Kaneider N, Rabensteiner A, Meierhofer C, Reinisch C, Romisch J, Wiedermann CJ: Cell-surface heparan sulfate proteoglycan-mediated regulation of human neutrophil migration by the serpin antithrombin III. Blood 2001, 97: 1079-1085. 10.1182/blood.V97.4.1079PubMed Dunzendorfer S, Kaneider N, Rabensteiner A, Meierhofer C, Reinisch C, Romisch J, Wiedermann CJ: Cell-surface heparan sulfate proteoglycan-mediated regulation of human neutrophil migration by the serpin antithrombin III. Blood 2001, 97: 1079-1085. 10.1182/blood.V97.4.1079PubMed
86.
Zurück zum Zitat Kaneider NC, Egger P, Dunzendorfer S, Weidermann CJ: Syndecan-4 as antithrombin receptor of human neutrophils. Biochem Biophys Res Commun 2001, 287: 42-46. 10.1006/bbrc.2001.5534PubMed Kaneider NC, Egger P, Dunzendorfer S, Weidermann CJ: Syndecan-4 as antithrombin receptor of human neutrophils. Biochem Biophys Res Commun 2001, 287: 42-46. 10.1006/bbrc.2001.5534PubMed
87.
Zurück zum Zitat Souter PJ, Thomas S, Hubbard AR, Poole S, Romisch J, Gray E: Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood. Crit Care Med 2001, 29: 134-139. 10.1097/00003246-200101000-00027PubMed Souter PJ, Thomas S, Hubbard AR, Poole S, Romisch J, Gray E: Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood. Crit Care Med 2001, 29: 134-139. 10.1097/00003246-200101000-00027PubMed
88.
Zurück zum Zitat Holschermann H, Romisch J, Leithauser B, Oelschläger C, Staubiz J, Strauss H, Tillman H: Antithrombin prevents activation of NF-κB in monocytes and endothelial cells [abstract P2048]. In International Congress of Thrombosis and Hemostasis; Paris, France. July 8–12 2001 Holschermann H, Romisch J, Leithauser B, Oelschläger C, Staubiz J, Strauss H, Tillman H: Antithrombin prevents activation of NF-κB in monocytes and endothelial cells [abstract P2048]. In International Congress of Thrombosis and Hemostasis; Paris, France. July 8–12 2001
89.
Zurück zum Zitat Reinisch C, Kaneider N, Rabensteiner A, Dunzendorfer B, Röuisch J, Weidermann CJ: Specific deactivation of monocyte and lymphocyte migration by ATIII concentrate. Intensive Care Med 2000, 26: S302, A341. Reinisch C, Kaneider N, Rabensteiner A, Dunzendorfer B, Röuisch J, Weidermann CJ: Specific deactivation of monocyte and lymphocyte migration by ATIII concentrate. Intensive Care Med 2000, 26: S302, A341.
90.
Zurück zum Zitat Hoffmann JN, Vollmar B, Inthorn D, Schildberg FW, Menger MD: Antithrombin reduces leukocyte adhesion during chronic endotoxemia by modulation of the cyclooxygenase pathway. Am J Cell Physiol 2000, 279: C98-C107. Hoffmann JN, Vollmar B, Inthorn D, Schildberg FW, Menger MD: Antithrombin reduces leukocyte adhesion during chronic endotoxemia by modulation of the cyclooxygenase pathway. Am J Cell Physiol 2000, 279: C98-C107.
91.
Zurück zum Zitat Nevière R, Tournoys A, Mordon S, Marechal X, Song FL, Jourdain M, Fourrier F: Antithrombin reduces mesenteric venular leukocyte interactions and small intestine injury in endotoxemic rats. Shock 2001, 15: 220-225.PubMed Nevière R, Tournoys A, Mordon S, Marechal X, Song FL, Jourdain M, Fourrier F: Antithrombin reduces mesenteric venular leukocyte interactions and small intestine injury in endotoxemic rats. Shock 2001, 15: 220-225.PubMed
92.
Zurück zum Zitat Hoffmann JN, Vollmar B, Laschke MW, Inthorn D, Kaneider NC, Dunzendorfer S, Wiedermann CJ, Romisch J, Schildberg FW, Menger MD: Adverse effect of heparin on antithrombin action during endotoxemia: microhemodynamic and cellular mechanisms. Thromb Haemost 2002, 88: 242-252.PubMed Hoffmann JN, Vollmar B, Laschke MW, Inthorn D, Kaneider NC, Dunzendorfer S, Wiedermann CJ, Romisch J, Schildberg FW, Menger MD: Adverse effect of heparin on antithrombin action during endotoxemia: microhemodynamic and cellular mechanisms. Thromb Haemost 2002, 88: 242-252.PubMed
93.
Zurück zum Zitat Giebler R, Schmidt U, Koch S, Peters J, Scherer R: Combined antithrombin III and C1-esterase inhibitor treatment decreases intravascular fibrin deposition and attenuates cardiorespiratory impairment in rabbits exposed to Escherichia coli endotoxin. Crit Care Med 1999, 27: 597-604. 10.1097/00003246-199903000-00042PubMed Giebler R, Schmidt U, Koch S, Peters J, Scherer R: Combined antithrombin III and C1-esterase inhibitor treatment decreases intravascular fibrin deposition and attenuates cardiorespiratory impairment in rabbits exposed to Escherichia coli endotoxin. Crit Care Med 1999, 27: 597-604. 10.1097/00003246-199903000-00042PubMed
94.
Zurück zum Zitat Taylor FB Jr, Emerson TE Jr, Jordan R, Chang AK, Blick KE: Antithrombin III prevents the lethal effects of E. coli infusion in the baboons. Circ Shock 1988, 26: 227-235.PubMed Taylor FB Jr, Emerson TE Jr, Jordan R, Chang AK, Blick KE: Antithrombin III prevents the lethal effects of E. coli infusion in the baboons. Circ Shock 1988, 26: 227-235.PubMed
95.
Zurück zum Zitat Kessler CM, Tang Z, Jacobs HM, Szymanski LM: The suprapharmacologic dosing of antithrombin concentrate for Staphylococcus aureus -induced disseminated intravascular coagulation in guinea pigs: substantial reduction of morbidity and mortality. Blood 1997, 89: 4393-4401.PubMed Kessler CM, Tang Z, Jacobs HM, Szymanski LM: The suprapharmacologic dosing of antithrombin concentrate for Staphylococcus aureus -induced disseminated intravascular coagulation in guinea pigs: substantial reduction of morbidity and mortality. Blood 1997, 89: 4393-4401.PubMed
96.
Zurück zum Zitat Minnema MC, Chang AC, Jansen PM, Lubbers YT, Pratt BM, Whittaker BG, Taylor FB, Hack CE, Friedman B: Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coli . Blood 2000, 95: 1117-1123.PubMed Minnema MC, Chang AC, Jansen PM, Lubbers YT, Pratt BM, Whittaker BG, Taylor FB, Hack CE, Friedman B: Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coli . Blood 2000, 95: 1117-1123.PubMed
97.
Zurück zum Zitat Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, Chalupa P, Atherstone A, Penzes I, Kubler A, Knaub S, Keinecke HO, Heinrichs H, Schindel F, Juers M, Bone RC, Opal SM, KyberSept Trial Study Group: High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 2001, 286: 1869-1878. 10.1001/jama.286.15.1869PubMed Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, Chalupa P, Atherstone A, Penzes I, Kubler A, Knaub S, Keinecke HO, Heinrichs H, Schindel F, Juers M, Bone RC, Opal SM, KyberSept Trial Study Group: High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 2001, 286: 1869-1878. 10.1001/jama.286.15.1869PubMed
98.
Zurück zum Zitat Rublee D, Opal SM, Schramm W, Keinecke H-O, Knaub S: Quality of life effects of AT III in sepsis survivors: results from the Kybersept trial. Crit Care 2002, 6: 249-256. 10.1186/cc1529 Rublee D, Opal SM, Schramm W, Keinecke H-O, Knaub S: Quality of life effects of AT III in sepsis survivors: results from the Kybersept trial. Crit Care 2002, 6: 249-256. 10.1186/cc1529
99.
Zurück zum Zitat Hesselvik JF, Malm J, Dahlback B, Blomback M: Protein C, protein S and C4b-binding protein in severe infection and septic shock. Thromb Haemost 1991, 65: 126-129.PubMed Hesselvik JF, Malm J, Dahlback B, Blomback M: Protein C, protein S and C4b-binding protein in severe infection and septic shock. Thromb Haemost 1991, 65: 126-129.PubMed
100.
Zurück zum Zitat Alcaraz A, Espana F, Sanchez-Cuenca J, Zuazu I, Estelles A, Aznar J, Vicente V: Activation of the protein C pathway in acute sepsis. Thromb Res 1995, 79: 83-93. 10.1016/0049-3848(95)00093-7PubMed Alcaraz A, Espana F, Sanchez-Cuenca J, Zuazu I, Estelles A, Aznar J, Vicente V: Activation of the protein C pathway in acute sepsis. Thromb Res 1995, 79: 83-93. 10.1016/0049-3848(95)00093-7PubMed
101.
Zurück zum Zitat Esmon CT: The endothelial cell protein C receptor. Thromb Haemost 2000, 83: 639-643.PubMed Esmon CT: The endothelial cell protein C receptor. Thromb Haemost 2000, 83: 639-643.PubMed
102.
Zurück zum Zitat Rezaie AR: Vitronectin functions as a cofactor for rapid inhibition of activated protein C by plasminogen activator inhibitor-1. Implications for the mechanism of profibrinolytic action of activated protein C. J Biol Chem 2001, 276: 15567-15570. 10.1074/jbc.C100123200PubMed Rezaie AR: Vitronectin functions as a cofactor for rapid inhibition of activated protein C by plasminogen activator inhibitor-1. Implications for the mechanism of profibrinolytic action of activated protein C. J Biol Chem 2001, 276: 15567-15570. 10.1074/jbc.C100123200PubMed
103.
Zurück zum Zitat Campbell WD, Lazoura E, Okada N, Okada H: Inactivation of C3a and C5a octapeptides by carboxypeptidase R and car-boxypeptidase N. Microbol Immunol 2002, 46: 131-134. Campbell WD, Lazoura E, Okada N, Okada H: Inactivation of C3a and C5a octapeptides by carboxypeptidase R and car-boxypeptidase N. Microbol Immunol 2002, 46: 131-134.
104.
Zurück zum Zitat Yuksel M, Okajima K, Uchiba M, Horiuchi S, Okabe H: Activated protein C inhibits lipopolysaccharide-induced tumor necrosis factor-α production by inhibiting activation of both nuclear factor-κB and activator protein-1 in human monocytes. Thromb Haemost 2002, 88: 267-273.PubMed Yuksel M, Okajima K, Uchiba M, Horiuchi S, Okabe H: Activated protein C inhibits lipopolysaccharide-induced tumor necrosis factor-α production by inhibiting activation of both nuclear factor-κB and activator protein-1 in human monocytes. Thromb Haemost 2002, 88: 267-273.PubMed
105.
Zurück zum Zitat White B, Schmidt M, Murphy C, Livingstone W, O'Toole D, Lawler M, O'Neill L, Kelleher D, Schwarz HP, Smith OP: Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor kappa B (NF-κB) and tumour necrosis factor alpha (TNF-α) production in the THP-1 monocytic cell line. Br J Haematol 2000, 110: 130-134. 10.1046/j.1365-2141.2000.02128.xPubMed White B, Schmidt M, Murphy C, Livingstone W, O'Toole D, Lawler M, O'Neill L, Kelleher D, Schwarz HP, Smith OP: Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor kappa B (NF-κB) and tumour necrosis factor alpha (TNF-α) production in the THP-1 monocytic cell line. Br J Haematol 2000, 110: 130-134. 10.1046/j.1365-2141.2000.02128.xPubMed
106.
Zurück zum Zitat Grey S, Hau H, Salem HH, Hancock WW: Selective effects of protein C on activation of human monocytes by lipopolysaccharide, interferon-gamma, or PMA: Modulation of effects on CD11b and CD14 but not CD25 or CD54 induction. Transplant Proc 1993, 25: 2913-2914.PubMed Grey S, Hau H, Salem HH, Hancock WW: Selective effects of protein C on activation of human monocytes by lipopolysaccharide, interferon-gamma, or PMA: Modulation of effects on CD11b and CD14 but not CD25 or CD54 induction. Transplant Proc 1993, 25: 2913-2914.PubMed
107.
Zurück zum Zitat Hancock WW, Grey ST, Hau L, Akalin E, Orthner C, Sayegh MH, Salem HH: Binding of activated protein C to a specific receptor on human mononuclear phagocytes inhibits intracellular calcium signaling and monocyte-dependent proliferative responses. Transplantation 1995, 60: 1525-1532.PubMed Hancock WW, Grey ST, Hau L, Akalin E, Orthner C, Sayegh MH, Salem HH: Binding of activated protein C to a specific receptor on human mononuclear phagocytes inhibits intracellular calcium signaling and monocyte-dependent proliferative responses. Transplantation 1995, 60: 1525-1532.PubMed
108.
Zurück zum Zitat Shu F, Kobayashi H, Fukudome K, Tsuneyoshi N, Kimoto M, Terao T: Activated protein C suppresses tissue factor expression on U937 cells in the endothelial protein C receptor-dependent manner. FEBS Lett 2000, 477: 208-212. 10.1016/S0014-5793(00)01740-3 Shu F, Kobayashi H, Fukudome K, Tsuneyoshi N, Kimoto M, Terao T: Activated protein C suppresses tissue factor expression on U937 cells in the endothelial protein C receptor-dependent manner. FEBS Lett 2000, 477: 208-212. 10.1016/S0014-5793(00)01740-3
109.
Zurück zum Zitat Riewald M, Petrovan RJ, Donner A, Mueller BM, Ruf W: Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 2002, 296: 1880-1882. 10.1126/science.1071699PubMed Riewald M, Petrovan RJ, Donner A, Mueller BM, Ruf W: Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 2002, 296: 1880-1882. 10.1126/science.1071699PubMed
110.
Zurück zum Zitat Joyce DE, Gelbert L, Ciaccia A, DeHoff B, Grinnell BW: Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. J Biol Chem 2001, 276: 11199-11203. 10.1074/jbc.C100017200PubMed Joyce DE, Gelbert L, Ciaccia A, DeHoff B, Grinnell BW: Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. J Biol Chem 2001, 276: 11199-11203. 10.1074/jbc.C100017200PubMed
111.
Zurück zum Zitat Bannerman DD, Tupper JC, Ricketts WA, Bennett CF, Winn RK, Harlan JM: A constitutive cytoprotective pathway protects endothelial cells from lipopolysaccharide-induced apoptosis. J Biol Chem 2001, 276: 14924-14932. 10.1074/jbc.M100819200PubMed Bannerman DD, Tupper JC, Ricketts WA, Bennett CF, Winn RK, Harlan JM: A constitutive cytoprotective pathway protects endothelial cells from lipopolysaccharide-induced apoptosis. J Biol Chem 2001, 276: 14924-14932. 10.1074/jbc.M100819200PubMed
112.
Zurück zum Zitat Mesters RM, Helterbrand J, Utterback BG, Yan B, Chao YB, Fernandez JA, Griffin JH, Hartman DL: Prognostic value of protein C concentrations in neutropenic patients at high risk for severe septic complications. Crit Care Med 2000, 28: 2209-2216.PubMed Mesters RM, Helterbrand J, Utterback BG, Yan B, Chao YB, Fernandez JA, Griffin JH, Hartman DL: Prognostic value of protein C concentrations in neutropenic patients at high risk for severe septic complications. Crit Care Med 2000, 28: 2209-2216.PubMed
113.
Zurück zum Zitat Fisher CJ, Yan SB: Protein C levels as a prognostic indicator of outcome in sepsis and related diseases. Crit Care Med 2000, 28: S49-S56. 10.1097/00003246-200009001-00011PubMed Fisher CJ, Yan SB: Protein C levels as a prognostic indicator of outcome in sepsis and related diseases. Crit Care Med 2000, 28: S49-S56. 10.1097/00003246-200009001-00011PubMed
114.
Zurück zum Zitat Taylor FB Jr, Peer GT, Lockhart MS, Ferrell G, Esmon CT: Endothelial protein C receptor plays an important role in protein C activation in vivo. Blood 2001, 97: 1685-1688. 10.1182/blood.V97.6.1685PubMed Taylor FB Jr, Peer GT, Lockhart MS, Ferrell G, Esmon CT: Endothelial protein C receptor plays an important role in protein C activation in vivo. Blood 2001, 97: 1685-1688. 10.1182/blood.V97.6.1685PubMed
115.
Zurück zum Zitat Xu J, Esmon NL, Esmon CT: Reconstitution of the human endothelial cell protein C receptor with the thrombomodulin in phosphatidylcholine vesicles enhances protein C activation. J Biol Chem 1999, 274: 6704-6710. 10.1074/jbc.274.10.6704PubMed Xu J, Esmon NL, Esmon CT: Reconstitution of the human endothelial cell protein C receptor with the thrombomodulin in phosphatidylcholine vesicles enhances protein C activation. J Biol Chem 1999, 274: 6704-6710. 10.1074/jbc.274.10.6704PubMed
116.
Zurück zum Zitat Fukudome K, Esmon CT: Identification, cloning and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol Chem 1994, 269: 26486-26491.PubMed Fukudome K, Esmon CT: Identification, cloning and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol Chem 1994, 269: 26486-26491.PubMed
117.
Zurück zum Zitat Conway EM, Rosenberg RD: Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Mol Cell Biol 1988, 8: 5588-5592.PubMedCentralPubMed Conway EM, Rosenberg RD: Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Mol Cell Biol 1988, 8: 5588-5592.PubMedCentralPubMed
118.
Zurück zum Zitat Krafte-Jacobs B, Brilli R: Increased circulating thrombomodulin in children with septic shock. Crit Care Med 1998, 26: 933-938. 10.1097/00003246-199805000-00032PubMed Krafte-Jacobs B, Brilli R: Increased circulating thrombomodulin in children with septic shock. Crit Care Med 1998, 26: 933-938. 10.1097/00003246-199805000-00032PubMed
119.
Zurück zum Zitat Gando S, Kameue T, Nanzaki S, Nakanishi Y: Cytokines, soluble thrombomodulin and disseminated intravascular coagulation in patients with systemic inflammatory response syndrome. Thromb Res 1995, 80: 519-526. 10.1016/0049-3848(95)00207-3PubMed Gando S, Kameue T, Nanzaki S, Nakanishi Y: Cytokines, soluble thrombomodulin and disseminated intravascular coagulation in patients with systemic inflammatory response syndrome. Thromb Res 1995, 80: 519-526. 10.1016/0049-3848(95)00207-3PubMed
120.
Zurück zum Zitat Faust SN, Levin M, Harrison OB, Goldin RD, Lockhart MS, Kondaveeti S, Laszik Z, Esmon CT, Heyderman RS: Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 2001, 345: 408-416. 10.1056/NEJM200108093450603PubMed Faust SN, Levin M, Harrison OB, Goldin RD, Lockhart MS, Kondaveeti S, Laszik Z, Esmon CT, Heyderman RS: Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 2001, 345: 408-416. 10.1056/NEJM200108093450603PubMed
121.
Zurück zum Zitat van der Poll T, Levi M, Hack CE, ten Cate H, van Deventer SJ, Eerenberg AJ, de Groot ER, Jansen J, Gallati H, Buller HR, et al.: Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med 1994, 179: 1253-1259.PubMed van der Poll T, Levi M, Hack CE, ten Cate H, van Deventer SJ, Eerenberg AJ, de Groot ER, Jansen J, Gallati H, Buller HR, et al.: Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med 1994, 179: 1253-1259.PubMed
122.
Zurück zum Zitat Liaw PCY, Ferrell GL, Loeb M, Foley R, Weitz JI, Esmon CT: Patients with severe sepsis vary markedly in their ability to generate activated protein C [abstract 1864]. Blood 2001, 98: 445a. Liaw PCY, Ferrell GL, Loeb M, Foley R, Weitz JI, Esmon CT: Patients with severe sepsis vary markedly in their ability to generate activated protein C [abstract 1864]. Blood 2001, 98: 445a.
123.
Zurück zum Zitat Conway EM, Van de Wouwer M, Pollefeyt S, Jurk K, Van Aken H, De Vriese A, Weitz JI, Weiler H, Hellings PW, Schaeffer P, Herbert JM, Collen D, Theilmeier G: The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor κB and mitogen-activated protein kinase pathways. J Exp Med 2002, 196: 565-577. 10.1084/jem.20020077PubMedCentralPubMed Conway EM, Van de Wouwer M, Pollefeyt S, Jurk K, Van Aken H, De Vriese A, Weitz JI, Weiler H, Hellings PW, Schaeffer P, Herbert JM, Collen D, Theilmeier G: The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor κB and mitogen-activated protein kinase pathways. J Exp Med 2002, 196: 565-577. 10.1084/jem.20020077PubMedCentralPubMed
124.
Zurück zum Zitat Gu J-M, Katsuura Y, Ferrell GL, Grammas P, Esmon CT: Endotoxin and thrombin elevate rodent endothelial cell protein C receptor mRNA levels and increase receptor shedding in vivo . Blood 2000, 95: 1687-1693.PubMed Gu J-M, Katsuura Y, Ferrell GL, Grammas P, Esmon CT: Endotoxin and thrombin elevate rodent endothelial cell protein C receptor mRNA levels and increase receptor shedding in vivo . Blood 2000, 95: 1687-1693.PubMed
125.
Zurück zum Zitat Kurosawa S, Esmon CT, Stearns-Kurosawa DJ: The soluble endothelial protein C receptor binds to activated neutrophils: Involvement of proteinase-3 and CDIIb/CDI8. J Immunol 2000, 165: 4697-4703.PubMed Kurosawa S, Esmon CT, Stearns-Kurosawa DJ: The soluble endothelial protein C receptor binds to activated neutrophils: Involvement of proteinase-3 and CDIIb/CDI8. J Immunol 2000, 165: 4697-4703.PubMed
126.
Zurück zum Zitat White B, Livingstone W, Murphy C, Hodgson A, Rafferty M, Smith OP: An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia. Blood 2000, 96: 3719-3724.PubMed White B, Livingstone W, Murphy C, Hodgson A, Rafferty M, Smith OP: An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia. Blood 2000, 96: 3719-3724.PubMed
127.
Zurück zum Zitat Smith OP, White B: Infectious pupura fulminans: diagnosis and treatment. Br J Haematol 1999, 104: 202-207. 10.1046/j.1365-2141.1999.01186.xPubMed Smith OP, White B: Infectious pupura fulminans: diagnosis and treatment. Br J Haematol 1999, 104: 202-207. 10.1046/j.1365-2141.1999.01186.xPubMed
128.
Zurück zum Zitat Takano S, Kimura S, Ohdama S, Aoki N: Plasma thrombomodulin in health and diseases. Blood 1990, 76: 2024-2029.PubMed Takano S, Kimura S, Ohdama S, Aoki N: Plasma thrombomodulin in health and diseases. Blood 1990, 76: 2024-2029.PubMed
129.
Zurück zum Zitat Stouthard JM, Levi M, Hack CE, Veenhof CH, Romijn HA, Sauerwein HP, van der Poll T: Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost 1996, 76: 738-742.PubMed Stouthard JM, Levi M, Hack CE, Veenhof CH, Romijn HA, Sauerwein HP, van der Poll T: Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost 1996, 76: 738-742.PubMed
130.
Zurück zum Zitat McGilvray ID, Rotstein OD: Role of the coagulation system in the local and systemic inflammatory response. World J Surg 1998, 22: 179-186. 10.1007/s002689900367PubMed McGilvray ID, Rotstein OD: Role of the coagulation system in the local and systemic inflammatory response. World J Surg 1998, 22: 179-186. 10.1007/s002689900367PubMed
131.
Zurück zum Zitat López-Aguirre Y, Páramo JA: Endothelial cell and hemostatic activation in relation to cytokines in patients with sepsis. Thromb Res 1999, 94: 95-101. 10.1016/S0049-3848(98)00200-XPubMed López-Aguirre Y, Páramo JA: Endothelial cell and hemostatic activation in relation to cytokines in patients with sepsis. Thromb Res 1999, 94: 95-101. 10.1016/S0049-3848(98)00200-XPubMed
132.
Zurück zum Zitat Coughlin SR: Thrombin receptor function and cardiovascular disease. Trends Cardiovasc Med 1994, 4: 77-83.PubMed Coughlin SR: Thrombin receptor function and cardiovascular disease. Trends Cardiovasc Med 1994, 4: 77-83.PubMed
133.
Zurück zum Zitat Kahn ML, Nakanishi-Matsue M, Shapiro MJ, Ishihara H, Coughlin SR: Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest 1999, 103: 879-887.PubMedCentralPubMed Kahn ML, Nakanishi-Matsue M, Shapiro MJ, Ishihara H, Coughlin SR: Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest 1999, 103: 879-887.PubMedCentralPubMed
134.
Zurück zum Zitat Hansen CB, Pyke C, Peterson LC, Rao LV: Tissue factor-mediated endocytosis, recycling, and degradation of factor VIIa by a clathrin-independent mechanism not requiring the cytoplasmic domain of tissue factor. Blood 2001, 97: 1712-1720. 10.1182/blood.V97.6.1712PubMed Hansen CB, Pyke C, Peterson LC, Rao LV: Tissue factor-mediated endocytosis, recycling, and degradation of factor VIIa by a clathrin-independent mechanism not requiring the cytoplasmic domain of tissue factor. Blood 2001, 97: 1712-1720. 10.1182/blood.V97.6.1712PubMed
135.
Zurück zum Zitat Riewald M, Kravchenko VV, Petrovan RJ, O'Brien PJ, Brass LF, Ulevitch RJ, Ruf W: Gene induction by coagulation factor Xa is mediated by activation of protease-activated receptor-1. Blood 2001, 97: 3109-3116. 10.1182/blood.V97.10.3109PubMed Riewald M, Kravchenko VV, Petrovan RJ, O'Brien PJ, Brass LF, Ulevitch RJ, Ruf W: Gene induction by coagulation factor Xa is mediated by activation of protease-activated receptor-1. Blood 2001, 97: 3109-3116. 10.1182/blood.V97.10.3109PubMed
136.
Zurück zum Zitat Lorant DE, Patel KD, McIntyre TM, McEver RP, Prescott SM, Zimmerman GA: Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils. J Cell Biol 1991, 115: 223-234.PubMed Lorant DE, Patel KD, McIntyre TM, McEver RP, Prescott SM, Zimmerman GA: Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils. J Cell Biol 1991, 115: 223-234.PubMed
137.
Zurück zum Zitat Coughlan AF, Hau H, Dunlop LC, Berndt MC, Hancock WW: P-selectin and platelet-activating factor mediate initial endotoxin-induced neutropenia. J Exp Med 1994, 179: 329-334.PubMed Coughlan AF, Hau H, Dunlop LC, Berndt MC, Hancock WW: P-selectin and platelet-activating factor mediate initial endotoxin-induced neutropenia. J Exp Med 1994, 179: 329-334.PubMed
138.
Zurück zum Zitat Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu YM, Sajer SA, Furie B: Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 1992, 359: 848-851. 10.1038/359848a0PubMed Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu YM, Sajer SA, Furie B: Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 1992, 359: 848-851. 10.1038/359848a0PubMed
139.
Zurück zum Zitat Loppnow H, Bil R, Hirt S, Schonbeck U, Herzberg M, Werdan K, Rietschel ET, Brandt E, Flad HD: Platelet-derived interleukin-1 induces cytokine production but nor proliferation of human vascular smooth muscle cells. Blood 1998, 91: 134-141.PubMed Loppnow H, Bil R, Hirt S, Schonbeck U, Herzberg M, Werdan K, Rietschel ET, Brandt E, Flad HD: Platelet-derived interleukin-1 induces cytokine production but nor proliferation of human vascular smooth muscle cells. Blood 1998, 91: 134-141.PubMed
140.
Zurück zum Zitat Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G, Kroczek RA: CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998, 391: 591-594. 10.1038/35393PubMed Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G, Kroczek RA: CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998, 391: 591-594. 10.1038/35393PubMed
141.
Zurück zum Zitat Aukrust P, Waehre T, Damas JK, Gullestad L, Solum NO: The inflammatory roles of platelets in acute coronary syndromes. Heart 2001, 86: 605-606. 10.1136/heart.86.6.605PubMedCentralPubMed Aukrust P, Waehre T, Damas JK, Gullestad L, Solum NO: The inflammatory roles of platelets in acute coronary syndromes. Heart 2001, 86: 605-606. 10.1136/heart.86.6.605PubMedCentralPubMed
142.
Zurück zum Zitat Lorant DE, Topham MK, Whatley RE, McEver RP, McIntyre TM, Prescott SM, Zimmerman GA: Inflammatory roles of P-selectin. J Clin Invest 1993, 92: 339-570. Lorant DE, Topham MK, Whatley RE, McEver RP, McIntyre TM, Prescott SM, Zimmerman GA: Inflammatory roles of P-selectin. J Clin Invest 1993, 92: 339-570.
143.
Zurück zum Zitat Grinnell BW, Hermann RB, Yan B: Human protein C inhibits selectin-mediated cell adhesion: role of unique fucosylated oligosaccharide. Glycobiology 1994, 4: 221-226.PubMed Grinnell BW, Hermann RB, Yan B: Human protein C inhibits selectin-mediated cell adhesion: role of unique fucosylated oligosaccharide. Glycobiology 1994, 4: 221-226.PubMed
144.
Zurück zum Zitat Taylor FB Jr, Chang ACK, Peer GT, Mather T, Blick K, Catlett R, Lockhart MS, Esmon CT: DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage. Blood 1991, 78: 364-368.PubMed Taylor FB Jr, Chang ACK, Peer GT, Mather T, Blick K, Catlett R, Lockhart MS, Esmon CT: DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage. Blood 1991, 78: 364-368.PubMed
Metadaten
Titel
Bench-to-bedside review: Functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis
verfasst von
Steven M Opal
Charles T Esmon
Publikationsdatum
01.02.2002
Verlag
BioMed Central
Erschienen in
Critical Care / Ausgabe 1/2003
Elektronische ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc1854

Weitere Artikel der Ausgabe 1/2003

Critical Care 1/2003 Zur Ausgabe

Sechs Maßnahmen gegen Regelschmerzen – von Krafttraining bis Yoga

05.06.2024 Dysmenorrhö Nachrichten

Um herauszufinden, wie gut sich körperliche Übungen dafür eignen, primäre Dysmenorrhö zu lindern, hat eine Studiengruppe sechs verschiedene Verfahren untersucht. Alle wirkten, doch eine Methode war Favorit.

Hereditäres Angioödem: Tablette könnte Akuttherapie erleichtern

05.06.2024 Hereditäres Angioödem Nachrichten

Medikamente zur Bedarfstherapie bei hereditärem Angioödem sind bisher nur als Injektionen und Infusionen verfügbar. Der Arzneistoff Sebetralstat kann oral verabreicht werden und liefert vielversprechende Daten.

Intoxikation ohne Alkoholaufnahme: An das Eigenbrauer-Syndrom denken!

05.06.2024 Internistische Diagnostik Nachrichten

Betrunken trotz Alkoholabstinenz? Der Fall einer 50-jährigen Patientin zeigt, dass dies möglich ist. Denn die Frau litt unter dem Eigenbrauer-Syndrom, bei dem durch Darmpilze eine alkoholische Gärung in Gang gesetzt wird.

Mit dem Seitenschneider gegen das Reißverschluss-Malheur

03.06.2024 Urologische Notfallmedizin Nachrichten

Wer ihn je erlebt hat, wird ihn nicht vergessen: den Schmerz, den die beim Öffnen oder Schließen des Reißverschlusses am Hosenschlitz eingeklemmte Haut am Penis oder Skrotum verursacht. Eine neue Methode für rasche Abhilfe hat ein US-Team getestet.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.